Arteriovenous Malformation

A cerebral arteriovenous malformation (AVM) is a tangle of abnormal vessels in which arteries connect directly to veins through a nidus, bypassing the normal capillary bed. This high-flow shunt can rupture and cause intracerebral or subarachnoid hemorrhage, or present with seizures or headache. Management weighs the lesion's hemorrhage risk against the risks of microsurgery, embolization, and radiosurgery.

Definition

A cerebral arteriovenous malformation is a congenital vascular lesion consisting of a nidus of abnormal vessels through which feeding arteries shunt directly into draining veins without an intervening capillary network, predisposing to hemorrhage.

Scope

This entry defines cerebral AVMs, describes the arteriovenous shunt and nidus, introduces the Spetzler-Martin grading system used to estimate surgical risk, and outlines the treatment modalities and the natural-history considerations that frame management. It is a reference and educational overview and does not provide individualized treatment guidance.

Core questions

• What defines the AVM nidus and the arteriovenous shunt?
• How does the Spetzler-Martin system grade AVMs and what does the grade represent?
• How do microsurgical resection, endovascular embolization, and stereotactic radiosurgery differ?
• What is the annual hemorrhage risk, and how does it inform whether to treat?

Key concepts

• Arteriovenous shunt and nidus
• Feeding arteries and draining veins
• Spetzler-Martin grade (size, eloquence, venous drainage)
• Intracerebral hemorrhage as a presentation
• Microsurgical resection
• Endovascular embolization
• Stereotactic radiosurgery

Mechanisms

In an AVM, blood passes from feeding arteries directly into draining veins through a nidus of abnormal vessels, without the normal high-resistance capillary bed. The resulting high-flow, low-resistance shunt exposes thin-walled vessels and draining veins to arterial pressure, predisposing to rupture and intracerebral or subarachnoid hemorrhage. The Spetzler-Martin grading system (Spetzler & Martin, 1986) summarizes the surgical risk of an AVM from three features — nidus size, eloquence of adjacent brain, and the presence of deep venous drainage — assigning a grade that predicts the difficulty and hazard of resection. Treatment seeks to obliterate the nidus by microsurgical removal, endovascular embolization, stereotactic radiosurgery, or a combination.

Clinical relevance

Understanding AVM anatomy, grading, and treatment modalities supports interpretation of the neurovascular literature and of trials weighing intervention against natural history. This entry describes how AVM risk and treatment options are characterized; it does not recommend whether or how a specific AVM should be treated, which depends on the lesion, the patient, and current evidence and is decided by the treating team.

Epidemiology

Cerebral AVMs are uncommon and often present in young or middle-aged adults, either after hemorrhage or with seizures, headache, or as incidental findings. The annual hemorrhage risk of an untreated AVM is one of the central parameters in management discussions, and a ruptured AVM is an important cause of intracerebral hemorrhage in younger patients.

Evidence & guidelines

The Spetzler-Martin grading system (Spetzler & Martin, 1986) is the standard framework for describing AVM surgical risk. The ARUBA trial (Mohr et al., 2014) compared medical management alone with interventional therapy for unruptured brain AVMs and informs the ongoing debate about intervening in unruptured lesions; its design and generalizability remain discussed in the literature.

History

Surgical treatment of cerebral AVMs advanced with microsurgical technique, and the introduction of the Spetzler-Martin grading system (1986) gave neurosurgeons a common language for describing lesion complexity and surgical risk. Endovascular embolization and stereotactic radiosurgery later expanded the treatment options, and the ARUBA trial (Mohr et al., 2014) brought randomized evidence to the question of whether unruptured AVMs should be treated at all.

Debates

Whether to treat unruptured brain AVMs

The ARUBA trial reported better short-term outcomes with medical management than with intervention for unruptured AVMs, but its enrolment, follow-up duration, and applicability to all lesions remain debated, leaving the decision lesion- and patient-specific.

Key figures

• Robert F. Spetzler
• J. P. Mohr
• Christian Stapf

Seminal works

• spetzler-martin-1986
• mohr-2014

Frequently asked questions

How is a cerebral AVM different from an aneurysm?

An AVM is an abnormal tangle of vessels shunting arteries directly into veins through a nidus, whereas an aneurysm is a focal outpouching of a single artery's wall. Both can rupture, but their structure, behaviour, and treatment differ.

What does the Spetzler-Martin grade describe?

It summarizes an AVM's surgical risk using three features — nidus size, eloquence of adjacent brain, and the presence of deep venous drainage — to indicate how difficult and hazardous resection is likely to be.